Literature DB >> 16098568

Phase singularities and filaments: simplifying complexity in computational models of ventricular fibrillation.

R H Clayton1, E A Zhuchkova, A V Panfilov.   

Abstract

In the whole heart, millions of cardiac cells are involved in ventricular fibrillation (VF). Experimental studies indicate that VF is sustained by re-entrant activity, and that each re-entrant wave rotates around a filament of phase singularity. Filaments act as organising centres, and offer a way to simplify and quantify the complex spatio-temporal behaviour observed in VF. Where a filament touches the surface of fibrillating myocardium re-entrant activity can be observed, however the behaviour of filaments within bulk ventricular myocardium is difficult to observe directly using present experimental techniques. Large scale computational simulations of VF in three-dimensional (3D) tissue offer a tool to investigate the properties and behaviour of filaments, and the aim of this paper is to review recent advances in this area as well as to compare recent computational studies of fibrillation in whole ventricle geometries.

Entities:  

Mesh:

Year:  2005        PMID: 16098568     DOI: 10.1016/j.pbiomolbio.2005.06.011

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  21 in total

1.  Origin choice and petal loss in the flower garden of spiral wave tip trajectories.

Authors:  Richard A Gray; John P Wikswo; Niels F Otani
Journal:  Chaos       Date:  2009-09       Impact factor: 3.642

2.  Simulation study on compressive laminar optical tomography for cardiac action potential propagation.

Authors:  Takumi Harada; Naoki Tomii; Shota Manago; Etsuko Kobayashi; Ichiro Sakuma
Journal:  Biomed Opt Express       Date:  2017-03-24       Impact factor: 3.732

3.  Electromechanical vortex filaments during cardiac fibrillation.

Authors:  J Christoph; M Chebbok; C Richter; J Schröder-Schetelig; P Bittihn; S Stein; I Uzelac; F H Fenton; G Hasenfuß; R F Gilmour; S Luther
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

4.  Panoramic optical mapping reveals continuous epicardial reentry during ventricular fibrillation in the isolated swine heart.

Authors:  Jack M Rogers; Gregory P Walcott; James D Gladden; Sharon B Melnick; Matthew W Kay
Journal:  Biophys J       Date:  2006-11-10       Impact factor: 4.033

Review 5.  Computational rabbit models to investigate the initiation, perpetuation, and termination of ventricular arrhythmia.

Authors:  Hermenegild J Arevalo; Patrick M Boyle; Natalia A Trayanova
Journal:  Prog Biophys Mol Biol       Date:  2016-06-19       Impact factor: 3.667

6.  A computational study of mother rotor VF in the human ventricles.

Authors:  R H Keldermann; K H W J ten Tusscher; M P Nash; C P Bradley; R Hren; P Taggart; A V Panfilov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-05       Impact factor: 4.733

7.  The role of fine-scale anatomical structure in the dynamics of reentry in computational models of the rabbit ventricles.

Authors:  Martin J Bishop; Gernot Plank
Journal:  J Physiol       Date:  2012-07-02       Impact factor: 5.182

8.  Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation.

Authors:  Brian O Bingen; Saïd F A Askar; Zeinab Neshati; Iolanda Feola; Alexander V Panfilov; Antoine A F de Vries; Daniël A Pijnappels
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

9.  Arrhythmogenesis in the heart: Multiscale modeling of the effects of defibrillation shocks and the role of electrophysiological heterogeneity.

Authors:  Hermenegild Arevalo; Blanca Rodriguez; Natalia Trayanova
Journal:  Chaos       Date:  2007-03       Impact factor: 3.642

10.  Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 2D simulation study.

Authors:  Juan F Gomez; Karen Cardona; Laura Martinez; Javier Saiz; Beatriz Trenor
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.